EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Spleen Cytokines Against Inflammatory Bowel Disease

    Over one hundred years ago at the University of Toronto Frederick Banting Charles Best and James Collip extracted protein insulin from the pancreas that saved the lives of millions of diabetics since then It is possible that the proteins extracted from the spleen can also help people with inflammatory bowel disease IBD

    Building Resilient Pharma Supply Chains to Strengthen Patient Care

    The failure to deliver a temperaturesensitive biologic or a critical maintenance drug on time is becoming a patient outcome crisis not just an operational inefficiency By fortifying our global logistics networks we proactively safeguard the availability of lifesaving therapies and essential healthcare supplies securing the healthcare industrys central promise to global health This strategic impera...

    The Impact of AI and Machine Learning on Drug Discovery

    Now and then an industry hits a point where the old ways no matter how trusted start to feel a bit like trying to run a marathon in hiking boots Drug discovery is in that spot For decades pharmaceutical RD leaned heavily on long painstaking experiments and the occasional stroke of luck Entire teams would spend years nudging molecules around waiting for a hint that something might work After all th...

    Navigating the Pharma Market: Strategies for Successful Pharmaceutical Sales

    Navigating the pharmaceutical market requires a blend of strategic planning industry knowledge and effective communication skills In this guide well explore key strategies for successful pharmaceutical sales in a way thats easy to understand

    Achieving Full Digital Maturity in Pharma Manufacturing: A Paperless Transformation Guide

    The pharmaceutical sector is changing radically as manufacturers do not rely on the past and dataintensive processes The vision of paperless pharma manufacturing is not a dream anymore it is a strategy based on the pressure of the regulators the complexity of operations and the need to accomplish faster and with accuracy production The center of this change is the digital pharma manufacturing and...

    Bridging the Biotech–Pharma Innovation Gap Through Strategic Partnerships

    Europe has never lacked ideas Its universities translational institutes and spinout companies consistently generate novel biology from geneediting tools to antibody engineering and mRNA platforms What the continent has struggled with is the journey that follows turning a validated mechanism into an approved reimbursed and reliably manufactured medicine That journey demands capital regulatory fluen...

TOP ARTICLES

  • 2

    The Impact of AI and Machine Learning on Drug Discovery

    Satyajit Shinde

    Artificial intelligence (AI) and machine learning (ML) are revolutionising drug discovery by dramatically accelerating the identification and development of new therapies. These technologies analyse v...

press releases Read more...

Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value

Jupiter Neurosciences Inc NASDAQ JUNS a clinicalstage biopharmaceutical company developing investigational therapies for neurodegenerative diseases today announced that the first patient has been dosed

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

Telix Pharmaceuticals Limited today announces that the first patients in the United States US have been dosed with Pixclara floretyrosine F or FFET its FDAapproved amino acid positron emission

VTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)

VTv Therapeutics Inc Nasdaq VTVT a latestage biopharmaceutical company advancing cadisegliatin a novel oral investigational therapy for type diabetes TD today announced that the Company has completed

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

Crescent Biopharma Inc Crescent or the Company Nasdaq CBIO a clinicalstage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients

12 - 13

Oct 2026

Pharmaceutics 2026

Village Hotel Changi, Singapor...

12 - 13

Oct 2026

2nd International Conference on Drug Discovery

Village Hotel Changi, Singapor...

21 - 23

Oct 2026

21 - 22

Oct 2026

22 - 23

Oct 2026

PDA Aseptic Symposium 2026

Congress Square Nakanoshima, O...

26 - 28

Oct 2026

ACHEMA Middle East 2026

RICEC, Riyadh, KSA, Saudi Arab...

26 - 28

Oct 2026

World Orphan Drug Congress

RAI, Amsterdam, Netherlands

27 - 28

Oct 2026

Pharma Manufacturing & Automation Convention 2026

Novotel Hyderabad Airport, Ind...

LATEST NEWS Read more...

Sensible Biotechnologies Secures $47 Million to Advance Cell-Based mRNA Platform

Sensible Biotechnologies has secured million in financing to advance and scale its platform for producing naturally modified messenger RNA mRNA medicines The funding includes a Series A round

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

PacBio and TychoBio have entered into a collaboration to generate fulllength RNA data for training artificial intelligence AI models designed to support RNA therapy development for rare diseases

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialise EXPAREL® in the European Union and UK

Pacira BioSciences has entered into a strategic agreement with Molteni Farmaceutici to expand access to EXPAREL bupivacaine liposome injectable suspension for postsurgical pain management across selected European markets

ORIC Pharmaceuticals and Cancer Research UK Partner to Advance CIP2A-Targeted Cancer Therapy

ORIC Pharmaceuticals has entered into an agreement with Cancer Research UK to advance ORIC a potential firstinclass therapy targeting Cancerous Inhibitor of PPA CIPA into clinical development

AstraZeneca Opens New Global R&D Centre in Kendall Square, Cambridge, Massachusetts

AstraZeneca has opened a new global strategic research and development RD centre in Kendall Square Cambridge Massachusetts expanding its presence in the region and strengthening its global research capabilities

Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development

Quotient Sciences and Acesion Pharma have announced a collaboration to use AIenhanced formulation development to support Acesions earlystage pipeline of smallmolecule treatments for atrial fibrillation